Results 191 to 200 of about 73,504 (266)

Skin exposure to soil microbiota elicits changes in cell-mediated immunity to pneumococcal vaccine. [PDF]

Sci Rep
Roslund MI, Nurminen N, Oikarinen S, Puhakka R, Grönroos M, Puustinen L, Kummola L, Parajuli A, Cinek O, Laitinen OH, Hyöty H, Sinkkonen A.   +11 more
europepmc   +1 more source

Neutrophils induce effective antibody responses to the pneumococcal conjugate vaccine by inhibiting regulatory T cells [PDF]

Essi Y. I. Tchalla, Anagha Betadpur, Andrew Y. Khalil, Elena López‐Camacho, Manmeet Bhalla, Ming Xian Chang, Elizabeth A. Wohlfert, Elsa N. Bou Ghanem   +7 more
openalex   +1 more source

Implementation of a Targeted Technologic Screening Tool to Increase Pneumococcal Vaccine Uptake in Health-System Retail Pharmacies: A Quality Improvement Initiative. [PDF]

Innov Pharm
Skogg A, Zagel AL, May O'Donnell R, Philbrick AM, Nelson MR, Schlichte A, Klasen KA.   +6 more
europepmc   +1 more source

A Phase 3 Randomized Trial Investigating the Safety, Tolerability, and Immunogenicity of V116, an Adult-Specific Pneumococcal Vaccine, Compared with PPSV23, in Adults ≥50 Years of Age (STRIDE-10). [PDF]

Vaccines (Basel)
Jotterand V, Jagannath V, Diaz AA, Velez JD, Letica A, Perez SN, Clark R, Caraco Y, Degen O, Park KH, Ünal S, Wittke F, Hurtado K, Churchill C, Zhang Y, Fernsler D, Li J, Buchwald UK, Platt H.   +18 more
europepmc   +1 more source

Demographic and Clinical Determinants of Conjugated Pneumococcal Vaccine Uptake and Short-Term All-Cause Mortality in Vaccinated and Unvaccinated Cohorts in Patients with Heart Failure and Reduced Ejection Fraction: A Prospective Cohort Study. [PDF]

Medicina (Kaunas)
Velibey Y, Kahraman E, Oz M, Gokalp M, Ozturk K, Melik M, Ulukoksal U, Yazar UE, Yucedag FF, Ozoguz E, Ozguclu E, Ocalmaz MS, Eren M, Bolca O, Güvenç TS.   +14 more
europepmc   +1 more source

A Phase 3 Clinical Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Pneumococcal Vaccine-Experienced Adults 50 Years of Age or Older (STRIDE-6). [PDF]

Clin Infect Dis
Scott P, Haranaka M, Choi JH, Stacey H, Dionne M, Greenberg D, Grijalva CG, Orenstein WA, Fernsler D, Gallagher N, Zeng T, Li J, Platt HL, STRIDE-6 Study Group.   +13 more
europepmc   +1 more source

Pneumococci remain the main cause of complicated pediatric pneumonia in the post-pandemic era despite extensive pneumococcal vaccine use. [PDF]

Pneumonia (Nathan)
Gomes-Silva J, Pinho MD, Friães A, Ramirez M, Melo-Cristino J, Silva-Costa C, Portuguese Group for the Study of Streptococcal Infections, Portuguese Study Group of Invasive Pneumococcal Disease of the Pediatric Infectious Disease Society.   +7 more
europepmc   +1 more source

Invasive Pneumococcal Disease Epidemiology and Serotype Replacement After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Ontario, Canada, 2007–2022

Ramandip Grewal, Kelty Hillier, Shelley L. Deeks, Allison H Yeung, Sarah E Wilson, Shinthuja Wijayasri, Tara Harris, Sarah A. Buchan   +7 more
openalex   +1 more source

Potential clinical efficacy of the 10-valent pneumococcal-Protein D conjugate vaccine in children with chronic suppurative lung diseases: A double-blind randomised controlled trial [PDF]

, 2016
Kerry-Ann O’Grady, Keith Grimwood, Allan W. Cripps, E. Kim Mulholland, Heidi Smith‐Vaughan, Margie Danchin, Nicholas Wood, Andrew Wilson, Ruth B. Thornton, Paul J. Torzillo, Peter Morris, Peter Richmond, Kirsten P. Perrett, Sheree Rablin, Anne Connor, Vikas Goyal, Tanya Stoney, Anne B. Chang   +17 more
openalex  

Vaccine Hesitancy Affecting Pneumococcal Vaccine Refusal in Older Adults with Morbidities. [PDF]

J Prim Care Community Health
Chitaree W, Buawangpong N, Yotruangsri T, Jiraporncharoen W, Pinyopornpanish K.   +4 more
europepmc   +1 more source